Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2017-05-19

Clinical Trial Update: Levofloxacin as an Empirical Therapy in Patients With Complicated Urinary Tract Infections [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating Levofloxacin as empirical therapy for complicated urinary tract infections. The current status is UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Levofloxacin (Levofloxacin)

Snippet

Sponsor: Dr. Reddy's Laboratories Limited | Conditions: Urinary Tract Infection | Phase 4 | Status: UNKNOWN